Hoss, Florian http://orcid.org/0000-0002-9231-5848
Mueller, James L.
Rojas Ringeling, Francisca http://orcid.org/0000-0001-8776-9768
Rodriguez-Alcazar, Juan F.
Brinkschulte, Rebecca
Seifert, Gerald
Stahl, Rainer
Broderick, Lori
Putnam, Chris D. http://orcid.org/0000-0002-6145-1265
Kolodner, Richard D. http://orcid.org/0000-0002-4806-8384
Canzar, Stefan http://orcid.org/0000-0003-4719-8010
Geyer, Matthias
Hoffman, Hal M.
Latz, Eicke http://orcid.org/0000-0003-1488-5666
Article History
Received: 25 November 2018
Accepted: 18 June 2019
First Online: 19 July 2019
Competing interests
: E.L. and M.G. are co-founders and consultants of IFM-Therapeutics. H.M.H is a consultant/speaker for Novartis and Sobi Pharmaceuticals, a member of IFM-Therapeutics scientific advisory board, and has received research funds from Jecure. The remaining authors declare no competing interests.